Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ferric pyrophosphate + folic acid** is a combination oral supplement primarily indicated for the management of iron deficiency and anemia, especially in women of reproductive age and pregnant women. Ferric pyrophosphate acts as an iron salt providing elemental iron necessary for erythropoiesis (production of red blood cells), while folic acid (vitamin B9) plays a central role in DNA synthesis and red blood cell maturation. The combination increases hemoglobin and improves iron parameters (e.g., ferritin, transferrin saturation) better tolerated than many other iron salts, with fewer gastrointestinal side effects. This combination is often found in multi-ingredient nutritional or medicinal supplements[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric pyrophosphate + folic acid.